Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osnate-D is an oral multi-nutrient supplement formulated to support bone health, prevent mineral deficiencies, and manage bone-related disorders. It contains a synergistic combination of ossein-hydroxyapatite complex (also referred to as ossein mineral complex) and cholecalciferol (vitamin D3). The ossein-hydroxyapatite complex provides a highly bioavailable, natural source of calcium and phosphorus in a physiological ratio, along with collagen, bone-specific proteins, and essential trace elements. Cholecalciferol is included to enhance the intestinal absorption of calcium and phosphorus, facilitating proper bone mineralization. Osnate-D is widely used to meet increased mineral requirements during pregnancy, lactation, and rapid growth phases, as well as for the prevention and treatment of osteoporosis, osteomalacia, rickets, and as an adjuvant to accelerate fracture healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ossein-hydroxyapatite complex + cholecalciferol.